Immix Payables Turnover from 2010 to 2024

IMMX Stock  USD 1.72  0.07  3.91%   
Immix Biopharma Payables Turnover yearly trend continues to be fairly stable with very little volatility. Payables Turnover will likely drop to 0 in 2024. Payables Turnover is a liquidity ratio that shows how quickly Immix Biopharma pays off its suppliers by dividing total purchases by average accounts payable. View All Fundamentals
 
Payables Turnover  
First Reported
2010-12-31
Previous Quarter
0.00381571
Current Value
0.003625
Quarterly Volatility
0.00425337
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Immix Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immix Biopharma's main balance sheet or income statement drivers, such as Tax Provision of 12.5 K, Net Interest Income of 360.6 K or Depreciation And Amortization of 3 K, as well as many indicators such as Dividend Yield of 0.0, Ptb Ratio of 7.68 or Book Value Per Share of 0.98. Immix financial statements analysis is a perfect complement when working with Immix Biopharma Valuation or Volatility modules.
  
Check out the analysis of Immix Biopharma Correlation against competitors.
For more information on how to buy Immix Stock please use our How to Invest in Immix Biopharma guide.

Latest Immix Biopharma's Payables Turnover Growth Pattern

Below is the plot of the Payables Turnover of Immix Biopharma over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. Immix Biopharma's Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immix Biopharma's overall financial position and show how it may be relating to other accounts over time.
Payables Turnover10 Years Trend
Slightly volatile
   Payables Turnover   
       Timeline  

Immix Payables Turnover Regression Statistics

Arithmetic Mean0.01
Geometric Mean0.01
Coefficient Of Variation68.95
Mean Deviation0
Median0
Standard Deviation0
Sample Variance0.000018
Range0.0136
R-Value0.41
Mean Square Error0.000016
R-Squared0.17
Significance0.12
Slope0.0004
Total Sum of Squares0.0003

Immix Payables Turnover History

2024 0.003625
2023 0.003816
2022 0.0149
2021 0.0173
2020 0.009198

About Immix Biopharma Financial Statements

Immix Biopharma investors use historical fundamental indicators, such as Immix Biopharma's Payables Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immix Biopharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immix Stock Analysis

When running Immix Biopharma's price analysis, check to measure Immix Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immix Biopharma is operating at the current time. Most of Immix Biopharma's value examination focuses on studying past and present price action to predict the probability of Immix Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immix Biopharma's price. Additionally, you may evaluate how the addition of Immix Biopharma to your portfolios can decrease your overall portfolio volatility.